473 related articles for article (PubMed ID: 10395371)
1. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
[TBL] [Abstract][Full Text] [Related]
2. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.
Marasco WA; LaVecchio J; Winkler A
J Immunol Methods; 1999 Dec; 231(1-2):223-38. PubMed ID: 10648940
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells and monocytes derived from CD34+ cells transduced with an intracellular antibody directed against human immunodeficiency virus type 1 Tat.
Poznansky MC; La Vecchio J; Silva-Arietta S; Porter-Brooks J; Brody K; Olszak IT; Adams GB; Ramstedt U; Marasco WA; Scadden DT
Hum Gene Ther; 1999 Oct; 10(15):2505-14. PubMed ID: 10543615
[TBL] [Abstract][Full Text] [Related]
6. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.
Duan L; Zhang H; Oakes JW; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1994 Nov; 5(11):1315-24. PubMed ID: 7893803
[TBL] [Abstract][Full Text] [Related]
7. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Duan L; Zhu M; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments.
Ho WZ; Lai JP; Bouhamdan M; Duan L; Pomerantz RJ; Starr SE
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1573-80. PubMed ID: 9840290
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.
Mhashilkar AM; Bagley J; Chen SY; Szilvay AM; Helland DG; Marasco WA
EMBO J; 1995 Apr; 14(7):1542-51. PubMed ID: 7537216
[TBL] [Abstract][Full Text] [Related]
11. Intrabodies to human immunodeficiency virus type 1.
Paillard F
Hum Gene Ther; 1999 Jun; 10(9):1425-7. PubMed ID: 10395367
[No Abstract] [Full Text] [Related]
12. Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies.
Bai J; Sui J; Zhu RY; Tallarico AS; Gennari F; Zhang D; Marasco WA
J Biol Chem; 2003 Jan; 278(3):1433-42. PubMed ID: 12401780
[TBL] [Abstract][Full Text] [Related]
13. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
[TBL] [Abstract][Full Text] [Related]
14. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.
Maggiorella MT; Baroncelli S; Michelini Z; Fanales-Belasio E; Moretti S; Sernicola L; Cara A; Negri DR; Buttò S; Fiorelli V; Tripiciano A; Scoglio A; Caputo A; Borsetti A; Ridolfi B; Bona R; ten Haaft P; Macchia I; Leone P; Pavone-Cossut MR; Nappi F; Ciccozzi M; Heeney J; Titti F; Cafaro A; Ensoli B
Vaccine; 2004 Sep; 22(25-26):3258-69. PubMed ID: 15308348
[TBL] [Abstract][Full Text] [Related]
15. Antitat gene therapy: a candidate for late-stage AIDS patients.
Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
[TBL] [Abstract][Full Text] [Related]
16. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
[TBL] [Abstract][Full Text] [Related]
17. In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.
Braun SE; Taube R; Zhu Q; Wong FE; Murakami A; Kamau E; Dwyer M; Qiu G; Daigle J; Carville A; Johnson RP; Marasco WA
Hum Gene Ther; 2012 Sep; 23(9):917-31. PubMed ID: 22734618
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.
Moreau E; Hoebeke J; Zagury D; Muller S; Desgranges C
J Virol; 2004 Apr; 78(7):3792-6. PubMed ID: 15016898
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
